Malaria P. Falciparum and P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test
Test Details
The Malaria P. falciparum & P. vivax Multiplex Detection Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate between the two most common species of malaria parasites, Plasmodium falciparum and Plasmodium vivax.
Malaria is a life-threatening disease caused by the transmission of the malaria parasite through the bite of infected female Anopheles mosquitoes. P. falciparum and P. vivax are the two main species responsible for most cases of malaria worldwide.
This multiplex detection differentiation test utilizes RNA detection to identify the presence of the malaria parasites in a patient’s blood sample. RNA detection is a sensitive method that allows for the detection of the genetic material of the parasites.
The test is qualitative, meaning it can determine whether the malaria parasites are present or not, but it does not provide information on the parasite load or the severity of the infection.
Differentiating between P. falciparum and P. vivax is important as they have different treatment approaches. P. falciparum infections are more severe and require prompt and aggressive treatment, while P. vivax infections can cause relapses and may require additional treatment to prevent recurrence.
By accurately identifying the species of malaria parasite present in a patient, healthcare providers can make informed decisions regarding the appropriate treatment and management of the infection.
Overall, the Malaria P. falciparum & P. vivax Multiplex Detection Differentiation (RNA Detection) Qualitative Test is a valuable tool in the diagnosis and management of malaria, allowing for the timely and accurate identification of the specific species of malaria parasite present in a patient’s blood sample.
Test Name
Malaria P. Falciparum and P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test
Components
Price: 1360.0 AED
Sample Condition
Whole blood, dried spot
Report Delivery
4th Working Day Email: 48 hours, On phone: 36 hours
Method
Real Time RT-PCR
Test Type
Viral
Doctor
Physician
Test Department
Genetics
Pre Test Information
Need to sign Consent document and bring any clinical history of patient for Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation (RNA Detection) Qualitative Test
| Test Name | Malaria P. Falciparum and P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 1360.0 AED |
| Sample Condition | Whole blood,dried spot |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time RT- PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forMalaria P. Falciparum & P. Vivax Multiplex Detection Differentiation (RNA Detection) QualitativeTest |
| Test Details |
The Malaria P. falciparum & P. vivax Multiplex Detection Differentiation (RNA Detection) Qualitative Test is a diagnostic test used to detect and differentiate between the two most common species of malaria parasites, Plasmodium falciparum and Plasmodium vivax. Malaria is a life-threatening disease caused by the transmission of the malaria parasite through the bite of infected female Anopheles mosquitoes. P. falciparum and P. vivax are the two main species responsible for most cases of malaria worldwide. This multiplex detection differentiation test utilizes RNA detection to identify the presence of the malaria parasites in a patient’s blood sample. RNA detection is a sensitive method that allows for the detection of the genetic material of the parasites. The test is qualitative, meaning it can determine whether the malaria parasites are present or not, but it does not provide information on the parasite load or the severity of the infection. Differentiating between P. falciparum and P. vivax is important as they have different treatment approaches. P. falciparum infections are more severe and require prompt and aggressive treatment, while P. vivax infections can cause relapses and may require additional treatment to prevent recurrence. By accurately identifying the species of malaria parasite present in a patient, healthcare providers can make informed decisions regarding the appropriate treatment and management of the infection. Overall, the Malaria P. falciparum & P. vivax Multiplex Detection Differentiation (RNA Detection) Qualitative Test is a valuable tool in the diagnosis and management of malaria, allowing for the timely and accurate identification of the specific species of malaria parasite present in a patient’s blood sample. |